Latest Breaking News On - Emerging variants - Page 8 : comparemela.com

Share this article Share this article SILVER SPRING, Md., Feb. 22, 2021 /PRNewswire/  Today, the U.S. Food and Drug Administration issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19. The FDA is committed to identifying efficient ways to modify medical products that either are in the pipeline or have been authorized for emergency use to address emerging variants, said Acting FDA Commissioner Janet Woodcock, M.D. We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the performance of these products. By issuing these guidances, we want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts. We need to arm health care providers with the best available di

United statesJanet woodcockDevelopment of monoclonal antibody products targetingDrug administrationPublic health emergencyOffice of media affairsEmergency use authorizationEvaluating impactViral mutationsMonoclonal antibody products targetingIncluding addressingEmerging variantsDeveloping drugsBiological productsMedia affairsUs food and drug administration